Action Radiotherapy is supported and run by some of the most experienced UK and international radiotherapy specialists.


Professor Pat Price

Professor Pat Price studied at Cambridge and King’s College Hospital Medical School, and qualified in 1981. She trained in general medicine in Cambridge and in oncology at the Royal Marsden Hospital.

She took up a research position under a Cancer Research Campaign Clinical Fellowship at the Institute of Cancer Research, London, and won the Cambridge University prize for best laboratory based MD. She then went on to work at the Hammersmith Hospital, London as a Senior Lecturer.

While at the Hammersmith Professor Price developed a research interest in molecular imaging for oncology and set up and headed the Medical Research Council and Cancer Research Campaign Positron Emission Tomography (PET) Oncology Programmes. She moved to Manchester in September 2000 to take up the Ralston Paterson Chair in Radiation Oncology and set up the new Wolfson Molecular Imaging Centre at the Christie Hospital. She is now Visiting Professor at Imperial College London.


Dr Christy Goldsmith

DChristy Goldsmithr Christy Goldsmith is a Clinical Oncologist specialising in an advanced radiotherapy technique called Stereotactic Body Radiotherapy (SBRT).  She is a Committee Member on the SABR Consortium UK, a Consortium which has been active in advocating for access for patients to SBRT treatment, as well as developing treatment guidelines, and furthering UK SBRT research.

Dr Goldsmith has presented Internationally at Radiotherapy meetings (ASTRO/ESTRO/RSS) on outcomes of UK SBRT.  She has also ran the British 10k London to fundraise for Action Radiotherapy.


Ms Tanya Levine



Peter Zarko-Flynn

Peter Zarko-Flynn is a media relations specialist with more than 25 years experience and is currently Director of Communications at Cancer Research UK. A former BBC News & Current Affairs producer, Peter has provided media relations advice to the UK’s leading health and science organisations, including the Francis Crick Institute, Imperial College London, the NHS National Cancer Action Team, Anthony Nolan, and NHS Blood & Transplant. He has been actively involved in raising awareness of radiotherapy since 2010.

Judith Potts

Judith Potts

Judith Potts is a former actress and current acting, voice and presentation coach. She writes speeches and presentations – often directing the latter.

She writes a (pro bono) Health Column for the Telegraph – principally about cancer and its attendant issues. She is the Founder of Esme’s Umbrella ( – the Awareness Campaign for the little-known frightening, hallucinatory condition called Charles Bonnet Syndrome. The Campaign seeks to raise awareness amongst the medical profession and the community, to prevent those who develop the condition from suffering in silence with the word ‘dementia’ hanging above them.  CBS is not a form of dementia but caused by deteriorating vision, which allows the brain to ‘fill in the blanks’ with images – which range from disturbing to terrifying.

She was diagnosed with breast cancer in 2008 for which she received a course of radiotherapy.

Professor Malcolm Mason

malcolm-masonProfessor Malcolm Mason is a clinician who specialises in the management of urological cancers, in which capacity he is the Chairman of the UK National Cancer Research Institute’s Prostate Cancer Clinical Studies Group. He is an experienced Clinical Researcher, has been the Chief Investigator for a number of Medical Research Council trials, and he has over 250 publications in his field. For the UICC (International Union Against Cancer) he Chairs the UK TNM Committee, and sits on the Core Group and the Prognostic Factors Task Group. Since 2003 he has been the Director of the Wales Cancer Bank, the UK’s first population-based tumour and blood sample collection, which to date has recruited over 3,900 patients. He also has laboratory research interests in prostate cancer, focused on immunology and on cancer metastasis.

Stephen Adolphus

Stephen Adolphus practices Maritime law. He was an early member of Action Radiotherapy and was involved with the charity in the early stages. In addition to helping with fund raising, he provided legal advise to the charity.

Stephen takes an interest in all forms of cancer treatments but takes a particular interest in the new developments in focused radiotherapy. He has family members who have benefited from a course of radiotherapy. He recognises the huge breakthroughs that have been made in this area of modern non-invasive radiotherapy.

Professor Philip Mayles

Professor Philip Mayles graduated from Gonville and Caius College, Cambridge in 1968 and completed a master of science degree in radiation physics at St Bartholemew’s Hospital Medical School. In 1986, he obtained a PhD from the Faculty of Medicine in London University, and was appointed head of clinical radiotherapy physics at the Royal Marsden Hospital. In 1994, he moved to Clatterbridge Centre for Oncology as head of the Physics Department. He oversaw the expansion of the department from having 5 linear accelerators with conventional collimators to 9 machines all equipped with multi leaf collimators and portal imaging devices. The department became one of the pioneers of intensity modulated radiotherapy and image guided radiotherapy in the UK.

Professor Philip Mayles became chairman of the Radiotherapy Topic Group of the Institute of Physics and Engineering in Medicine as was instrumental in producing Report 75 on the design of radiotherapy treatment facilities and Report 81 on quality assurance in radiotherapy. Both reports are now published as second editions. He has an active interest in research especially in improving the physical basis of radiotherapy treatment and treatment planning.

Dr Clive Harmer

Dr. Clive Harmer was  consultant in Clinical Oncology and head of the Thyroid Unit at the Royal Marsden Hospital, London. As a medico-legal expert witness he specialises in breach of duty and causation covering a broad spectrum of different malignancies. He is co-editor of “Practical Management of Thyroid Cancer” – second edition to be published in 2018, and has over 200 peer-reviewed publications with the majority on thyroid disease. Clive is also patron of the Butterfly Thyroid Cancer Trust, and council member of the Medical Society of London.